论文信息 - The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia - 字舞流文

The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia

J. Hernández-Rivas | M. Sánchez-Martín | I. García-Tuñón | R. Benito | M. Hernández-Sánchez | C. Guerrero | María Hernández-Rivas | Verónica | Jesús | J. Ordoñez | Alonso-Pérez | Verónica Alonso-Pérez | Miguel Álamo-Quijada